Wanted: better policies and incentives to revitalize R&D for new antimicrobial drugs
JAMES ARCHER/CDC
The world needs new antimicrobial drugs. To get them, we need new policies and incentives for the dwindling number of companies working in this space.


No hay comentarios:
Publicar un comentario